Select a Region North America

Insights

Insights From Our Experts

Articles

Cutting-edge Insights from EVERSANA's Global Value & Evidence Team
Filling in the Gaps: Predicting Treatment Effects From Surrogate Endpoints

Over the past 15 years, the treatment landscape for first-line metastatic castration-resistant prostate cancer (mCRPC) has undergone significant changes, marked by the approval and investigation of several new therapies. With multiple pharmacological treatments available for first-line…

In-Depth with an Industry Leader: Global Launch Ambitions and Paradigm Shifts

Biotech enterprises, driven by the dual goals of treating a maximum patient population and ensuring a robust return on investment, must strategically navigate the complex landscape of global commercialization. Although the United States remains a crucial…

Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success

Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine…

Empower to Impact: Advocacy Training for Meaningful Change

Advocacy training is central to empowering advocacy champions, and for EVERSANA’s Advocacy & PR group in Canada, it is at the core of the work that they do. In a recent conversation, Ryan Clarke, LL.B., senior…

Key Insights from ARCS 2024: Shaping the Future of HTA and Reimbursement in Australia

EVERSANA’s senior director of pricing and market access for the APAC region, Amish Chaturvedi, recently chaired four insightful panel sessions discussing reimbursement policies at the annual ARCS Conference in Australia, covering key policy topics that impact…

EVERSANA Named Global Host and Presenting Sponsor of Frontiers Health 2024, Bringing Innovators Together Across Europe and Beyond to Transform Healthcare

Today EVERSANA, a leading provider of global commercial services to the life sciences industry, is proud to announce that we will be the global host and presenting sponsor for Frontiers Health 2024. The two-day event, which…

Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know

Unlock the full potential of your Integrated Delivery Network (IDN) strategies with EVERSANA’s latest Market Research & Insights Report. Drug manufacturers are engaging with IDNs to address pain points and trends, optimize patient outcomes, and foster…

The Integral Role of Global Indirect Treatment Comparison in Europe’s JCA

Discover the integral role of Global Indirect Treatment Comparison (ITC) Programs in Europe’s Joint Clinical Assessment (JCA) in this insightful piece by EVERSANA. Learn why a global ITC program is not just beneficial but essential for…

Transforming the Future of Pharma Commercialization Through Medical Affairs

  The pharmaceutical industry is rapidly evolving, and Medical Affairs is at the forefront of this transformation. As a clinician, it is an exciting time to think about the possibilities and how several emerging factors are…

Screenshot of our blog: The New AMCP Dossier
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach

The Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions is the industry standard for communicating clinical and economic information to meet the evidentiary requirements/needs of healthcare decision-makers (HCDMs) in the United States. The latest…